Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Bipolar Disorder
.
Show all posts
Showing posts with label
Bipolar Disorder
.
Show all posts
Wednesday, April 29, 2020
FDA Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar Disorder
›
Alkermes plc (Nasdaq: ALKS) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug...
›
Home
View web version
